Search Results 601-610 of 17562 for metformin

  1. A Study Of Biomarkers To Predict Cancer Therapy-related Cardiotoxicity - Mayo Clinic

    About this study. The primary purpose of this study is to collect Biospecimens from patients who developed chemotherapy related cardiac toxicity (CRCT) and ...

  2. Eosinophils in Insulin Sensitivity in Humans - Mayo Clinic

    Aim 1: To determine the metabolic effects of decreasing circulating EOS in healthy subjects. Mepolizumab is an FDA-approved drug that selectively reduces ...

  3. Gastroenterology and Hepatology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  4. Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

    Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...

  5. A Study to Evaluate Pregnancy in Adults with Congenital Heart Disease - Mayo Clinic

    About this study. The purpose of this study is to assess the experience of pregnancy within selected populations of women with congenital heart disease ...

  6. Nintedanib (oral route) - Mayo Clinic

    This medicine is also used to slow the rate of decline in lung function in people with systemic sclerosis-associated interstitial lung disease. Nintedanib ...

  7. Drugs and Supplements that Start with T - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “T” to learn about drug side effects, proper use and ...

  8. Pemigatinib (oral route) - Side effects & dosage - Mayo Clinic

    Pemigatinib is also used to treat myeloid/lymphoid neoplasms (blood cancer) that has come back or did not respond to treatment in patients who have a certain ...

  9. Ticagrelor (oral route) - Side effects & dosage - Mayo Clinic

    Ticagrelor is used alone or together with aspirin to lessen the chance of heart attack or stroke in patients with acute coronary syndrome (ACS) or a history of ...

  10. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...